ZNTL (Zentalis Pharmaceuticals) Forward Dividend Yield %: 0.00% (As of Jul. 08, 2026)


ZNTL Zentalis Pharmaceuticals Inc ZNTL
30 GF Score
Price $4.74
! 3 Warning Signs
View Full Analysis

What is Zentalis Pharmaceuticals Forward Dividend Yield %?

Zentalis Pharmaceuticals ZNTL -0.84% 30 Forward Dividend Yield % is 0.00% as of Jul. 08, 2026. GuruFocus rates ZNTL with a GF Score™ of 30/100. The stock has 3 warning signs investors should review. Among 146 Biotechnology companies, Zentalis Pharmaceuticals ranks worse than 684930.82% on this metric.

As of today (2026-07-08), the Forward Annual Dividend Yield of Zentalis Pharmaceuticals is 0.00%.

As of today (2026-07-08), the Trailing Annual Dividend Yield of Zentalis Pharmaceuticals is 0.00%.

ZNTL's Forward Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.285
* Ranked among companies with meaningful Forward Dividend Yield % only.

Zentalis Pharmaceuticals's Dividends per Share for the three months ended in Mar. 2026 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Zentalis Pharmaceuticals  (NAS:ZNTL) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Zentalis Pharmaceuticals Forward Dividend Yield % Related Terms

ZNTL vs ELDN, GLSI, SABS: Forward Dividend Yield % Comparison

For the Biotechnology subindustry, Zentalis Pharmaceuticals's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zentalis Pharmaceuticals Forward Dividend Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zentalis Pharmaceuticals's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Zentalis Pharmaceuticals's Forward Dividend Yield % falls into.


ZNTL
30GF Score
Zentalis Pharmaceuticals Inc ZNTL
Forward Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zentalis Pharmaceuticals Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

What does a Forward Dividend Yield % of 0.00% mean?
Zentalis Pharmaceuticals (ZNTL) has a Forward Dividend Yield % of 0.00% as of Jul. 08, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Zentalis Pharmaceuticals and its competitors. According to the industry distribution chart, Zentalis Pharmaceuticals ranks #999999 out of 146 companies in the Biotechnology industry.
Is Zentalis Pharmaceuticals' Forward Dividend Yield % too high?
Zentalis Pharmaceuticals' current Forward Dividend Yield % is 0.00%. Based on the distribution chart, Zentalis Pharmaceuticals ranks #999999 out of 146 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Zentalis Pharmaceuticals has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Zentalis Pharmaceuticals' Forward Dividend Yield % compare to ELDN and GLSI?
According to the Biotechnology industry distribution chart, Zentalis Pharmaceuticals ranks #999999 out of 146 companies for Forward Dividend Yield %. This places Zentalis Pharmaceuticals in the lower half of its industry. The industry median Forward Dividend Yield % is 1.29. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Biotechnology company?
The median Forward Dividend Yield % among Biotechnology companies is 1.29, based on 146 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Zentalis Pharmaceuticals and its competitors. For the Biotechnology industry, the median Forward Dividend Yield % is 1.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zentalis Pharmaceuticals's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zentalis Pharmaceuticals stock overvalued right now?
Zentalis Pharmaceuticals (ZNTL) has a current Forward Dividend Yield % of 0.00%. The current Forward Dividend Yield % is 0.00%. Zentalis Pharmaceuticals' overall GF Score™ is 30/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Zentalis Pharmaceuticals (ZNTL), the current Forward Dividend Yield % is 0.00% as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Zentalis Pharmaceuticals Business Description

Address 10275 Science Center Drive, Suite 200, San Diego, CA, USA, 92121
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
30GF Score

Get the complete analysis for ZNTL

Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.74
Price